LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,798 | -98.0% | 30 | -97.6% | 0.00% | -98.5% |
| Q2 2023 | $91,639 | +8208.2% | 1,271 | +8373.3% | 0.07% | +6600.0% |
| Q1 2023 | $1,103 | -98.3% | 15 | -97.8% | 0.00% | -98.4% |
| Q3 2020 | $66,000 | -77.9% | 693 | -74.0% | 0.06% | -77.7% |
| Q2 2020 | $299,000 | +116.7% | 2,670 | +143.8% | 0.27% | +97.8% |
| Q1 2019 | $138,000 | +97.1% | 1,095 | +329.4% | 0.14% | +109.1% |
| Q3 2018 | $70,000 | +29.6% | 255 | -1.9% | 0.07% | +32.0% |
| Q2 2018 | $54,000 | +25.6% | 260 | 0.0% | 0.05% | +28.2% |
| Q1 2018 | $43,000 | – | 260 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |